3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Breast Neoplasms
5
Sarcoma
2
Radiation Injuries
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Lymphedema
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Laryngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Flap Necrosis
1
Fibrosis
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
409
Methotrexate
246
Cytarabine
231
Vincristine
188
fludarabine phosphate
172
Dexamethasone
169
fludarabine
143
Etoposide
143
Peripheral Blood Stem Cell Transplantation
136
Filgrastim
132
Whole-Body Irradiation
116
Mycophenolic Acid
115
Busulfan
112
Doxorubicin
109
Tacrolimus
106
Mercaptopurine
105
Cyclosporine
95
Radiotherapy
93
Melphalan
93
Rituximab
90
pegaspargase
88
Prednisone
84
Asparaginase
84
Daunorubicin
82
Granulocyte Colony-Stimulating Factor
74
blinatumomab
72
Antilymphocyte Serum
71
Calcium Dobesilate
69
Clofarabine
58
Thiotepa
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Hyperbaric Oxygenation
×
Clear all
NCT03739502
2025-07-08
HBO-UBC
University of Rochester
Phase 2
Recruiting
64 enrolled